Literature DB >> 4309191

Tissue distribution of glycosphingolipids in a case of Fabry's disease.

J M Schibanoff, S Kamoshita, J S O'Brien.   

Abstract

A survey was made of the glycolipid composition of various tissues, including liver, spleen, kidney (cortex and medulla), lymph node, pancreas, prostate gland, heart muscle, thenar muscle, gastrointestinal smooth muscle, frontal cerebral cortex, anterior thalamus, brain stem, a peripheral autonomic ganglion, and renal arterial intima and media, from a patient who died with Fabry's disease. The tissues had been fixed in formalin for 3 yr. Analytical data on trihexosyl ceramide from heart muscle and pancreas indicate a structure identical to trihexosyl ceramide from kidney: galactosylgalactosylglucosyl ceramide. Fatty acid compositions of trihexosyl ceramide and dihexosyl ceramide revealed a wide range of fatty acids, with 16:0, 18:0, 20:0, 22:0, 24:0, and 24:1 predominating. These glycolipids comprised 10-41% of the total lipid in the formalin-fixed organs studied. Trihexosyl ceramide predominated in all tissues and was the only glycolipid found in muscle tissues, lymph node, and arterial tissues. Dihexosyl ceramide was found in kidney, pancreas, liver, spleen, and cerebral tissues. The accumulation of trihexosyl ceramide in cardiac muscle and arterial tissues may account in part for the cardiovascular complications so prominent in Fabry's disease.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4309191

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  11 in total

Review 1.  Basic findings and current developments in sphingolipidoses.

Authors:  H Pilz; R Heipertz; D Seidel
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

2.  Cellular and tissue localization of globotriaosylceramide in Fabry disease.

Authors:  Hasan Askari; Christine R Kaneski; Cristina Semino-Mora; Priya Desai; Agnes Ang; David E Kleiner; Lorah T Perlee; Martha Quezado; Linda E Spollen; Brandon A Wustman; Raphael Schiffmann
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

3.  Significance of muscle biopsies in neuronal ceroid-lipofuscinoses.

Authors:  H H Goebel; W Zeman; H Pilz
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-10       Impact factor: 10.154

Review 4.  Progress in investigations of sphingolipidoses.

Authors:  M Adachi; L Schneck; B W Volk
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

5.  [Neurological symptoms in Fabry's disease. Report of a case with neuromuscular symptoms and review of the literature].

Authors:  H Pilz; E Volles; H A Paul; A Denden
Journal:  Z Neurol       Date:  1972

6.  Fabry's disease: evidence for a physically altered -galactosidase.

Authors:  M W Ho; S Beutler; L Tennant; J S O'Brien
Journal:  Am J Hum Genet       Date:  1972-05       Impact factor: 11.025

7.  Neuropathological and biochemical studies in Fabry's disease.

Authors:  T Tabira; I Goto; Y Kuroiwa; M Kikuchi
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

8.  Niemann-Pick disease type C with enhanced glycolipid storage. Report on further case of so-called lactosylceramidosis.

Authors:  M Elleder; A Jirásek; F Smíd; J Ledvinová; G T Besley; M Stopeková
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

Review 9.  Lysosomal storage diseases.

Authors:  Carlos R Ferreira; William A Gahl
Journal:  Transl Sci Rare Dis       Date:  2017-05-25

10.  Anderson-Fabry's disease: neuropathological and neurochemical investigation.

Authors:  F Tagliavini; V Pietrini; F Gemignani; A Lechi; R Pallini; A Federico
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.